Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.

Literature DB >> 3435111

In vitro activity of ciprofloxacin against aerobic bacteria isolated in a southern European hospital.

G Cornaglia¹, R Pompei, B Dainelli, G Satta.

Abstract

The activity of ciprofloxacin was evaluated against 1,204 isolates freshly isolated in Southern Europe, including 193 isolates of 10 species never studied before. Ciprofloxacin proved more active than other quinolones and very active in absolute terms against the 10 new species and showed against the other species an activity close to that reported for isolates from other geographic areas.

Entities: Chemical

Mesh：

Substances：
Ciprofloxacin

Year: 1987 PMID： 3435111 PMCID： PMC175009 DOI： 10.1128/AAC.31.10.1651

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

16 in total

1. Simplified lyogroup system, a new method for routine identification of staphylococci: description and comparison with three other methods.

Authors: P E Varaldo; G Grazi; O Soro; G Cisani; G Satta
Journal: J Clin Microbiol Date: 1980-07 Impact factor: 5.948

2. Activity of ciprofloxacin (BAYo 9867) against Pseudomonas aeruginosa and ampicillin-resistant Enterobacteriaceae.

Authors: C Roy; A Foz; C Segura; M Tirado; M Teixell; D Teruel
Journal: Infection Date: 1983 Nov-Dec Impact factor: 3.553

3. In vitro susceptibilities of four species of coagulase-negative staphylococci.

Authors: R J Fass; V L Helsel; J Barnishan; L W Ayers
Journal: Antimicrob Agents Chemother Date: 1986-10 Impact factor: 5.191

4. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors: N X Chin; H C Neu
Journal: Antimicrob Agents Chemother Date: 1984-03 Impact factor: 5.191

5. Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors: A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal: Antimicrob Agents Chemother Date: 1984-05 Impact factor: 5.191

6. Recognition of group D streptococcal species of human origin by biochemical and physiological tests.

Authors: R R Facklam
Journal: Appl Microbiol Date: 1972-06

7. In vitro activity of ciprofloxacin, a new carboxyquinoline antimicrobial agent.

Authors: G M Eliopoulos; A Gardella; R C Moellering
Journal: Antimicrob Agents Chemother Date: 1984-03 Impact factor: 5.191

8. In vitro activity of ciprofloxacin (Bay o 9867).

Authors: R J Fass
Journal: Antimicrob Agents Chemother Date: 1983-10 Impact factor: 5.191

9. In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.

Authors: A Bauernfeind; C Petermüller
Journal: Eur J Clin Microbiol Date: 1983-04 Impact factor: 3.267

10. Comparative in-vitro activity of quinolone carboxylic acids against Proteeae.

Authors: P M Hawkey; C A Hawkey
Journal: J Antimicrob Chemother Date: 1984-11 Impact factor: 5.790

6 in total

1. Therapeutic failure and selection of resistance to quinolones in a case of pneumococcal pneumonia treated with ciprofloxacin.

Authors: E Pérez-Trallero; J M Garcia-Arenzana; J A Jimenez; A Peris
Journal: Eur J Clin Microbiol Infect Dis Date: 1990-12 Impact factor: 3.267